Cassava Sciences Inc reports results for the quarter ended in June - Earnings Summary

Filana Therapeutics

03/08/2023 15:32

* Cassava Sciences Inc  SAVA.OQ  reported a quarterly
adjusted
loss of 63 cents​​ per share for the quarter ended in June. The
mean expectation of two analysts for the quarter was for a loss
of 59 cents per share.
    * Reported revenue was zero​; analysts expected zero. 
    * Cassava Sciences Inc's reported EPS for the quarter was a
loss
of 63 cents​.
    * The mean earnings estimate of analysts had risen by
about 3.3%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * Cassava Sciences Inc shares had fallen by 14.4% this
quarter and
lost 29.0% so far this year.
    * The company reported a quarterly loss of $26.38 million.
    * Wall Street's median 12-month price target for Cassava
Sciences
Inc is $112.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data
August 3 at 02:32 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2023      -0.59          -0.63          Missed
 Mar. 31 2023      -0.55          -0.58          Missed
 Dec. 31 2022      -0.56          -0.47          Beat
 Sep. 30 2022      -0.48          -0.51          Missed